|
MAPKAPK5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.4195999970853E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.648500E-04 |
| Normal-vs-Stage2 |
3.473500E-02 |
| Normal-vs-Stage3 |
1.92179605562615E-11 |
| Normal-vs-Stage4 |
1.12460000001313E-06 |
| Stage1-vs-Stage2 |
9.942400E-01 |
| Stage1-vs-Stage3 |
1.55974999999087E-05 |
| Stage1-vs-Stage4 |
1.319890E-02 |
| Stage2-vs-Stage3 |
5.257700E-03 |
| Stage2-vs-Stage4 |
1.032180E-01 |
| Stage3-vs-Stage4 |
2.462800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.11639999969648E-08 |
| Normal-vs-AfricanAmerican |
6.977200E-03 |
| Normal-vs-Asian |
5.917200E-01 |
| Caucasian-vs-AfricanAmerican |
4.451800E-01 |
| Caucasian-vs-Asian |
3.573000E-01 |
| AfricanAmerican-vs-Asian |
5.775600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.22730000501537E-08 |
| Normal-vs-Female |
2.01649999999054E-05 |
| Male-vs-Female |
2.366400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.482000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.52648999999228E-05 |
| Normal-vs-Age(61-80Yrs) |
1.61160000011762E-07 |
| Normal-vs-Age(81-100Yrs) |
1.637870E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.164800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.439400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.574200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.106600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.181200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.039600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.161000E-01 |
| Normal-vs-Grade 2 |
2.188100E-04 |
| Normal-vs-Grade 3 |
1.2602000554196E-09 |
| Normal-vs-Grade 4 |
1.04900000019725E-07 |
| Grade 1-vs-Grade 2 |
2.745000E-01 |
| Grade 1-vs-Grade 3 |
3.468200E-02 |
| Grade 1-vs-Grade 4 |
2.247900E-02 |
| Grade 2-vs-Grade 3 |
2.718500E-03 |
| Grade 2-vs-Grade 4 |
1.417800E-03 |
| Grade 3-vs-Grade 4 |
2.896000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.388900E-04 |
| Normal-vs-ccB subtype |
1.423940E-04 |
| ccA subtype-vs-ccB subtype |
5.845200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.71689999997715E-06 |
| Normal-vs-N1 |
1.494570E-01 |
| N0-vs-N1 |
9.815000E-01 |
|
|
